Tarsus Pharmaceuticals, Inc. - Common Stock (TARS)

CUSIP: 87650L103

Q4 2025 13F Holders as of 31 Dec 2025

Security type / class
Equity / Common Stock
Total 13F shares
44,051,147
Total 13F value
$3,606,397,271
Holder snapshot 6 visible 7 signals
Share change
-1,686,793
Put/Call ratio
2.5%
SEC-reported price per share
$81.88
Number of holders
246
Value change
-$100,796,094
Number of buys
128
Open additional details 1 more signal available
Number of sells
108
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
42,282,321

Security key

87650L103

Report period

Q4 2025

Institutions

246

Top holders

10

TARS full security history Ownership snapshot Full 13F holder table Newer quarter: Q1 2026 Previous quarter: Q3 2025 Tarsus Pharmaceuticals, Inc. SEC filings Tarsus Pharmaceuticals, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of TARS - Tarsus Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
RTW INVESTMENTS, LP
Disclosed value leader
BlackRock, Inc.
Comparable rows
15/15
Latest evidence
30 Sep 2025
13F 13D/G 3/4/5 Lead comparable stake: 8.1% 13D/G row: RTW INVESTMENTS, LP Showing 1-6 of 15 holder rows.

Quick read

RTW INVESTMENTS, LP leads the comparable SEC ownership view at 8.1%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens RTW INVESTMENTS, LP's linked filing trail.
Comparable ownership Top 5
RTW INVESTMENTS, LP 8.1%
BlackRock, Inc. 7.4%
Cowen Financial Products LLC 4.9%
MORGAN STANLEY 4.7%
TANG CAPITAL MANAGEMENT LLC 2.8%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
RTW INVESTMENTS, LP
13F 13D/G 3/4/5
Company · 10%+ Owner
13F 13D/G 3/4/5
8.1%
from 13D/G
$188,835,021
3,177,436 shares
 — 30 Sep 2025
BlackRock, Inc.
13F 13D/G
Company
13F 13D/G
7.4%
from 13D/G
$224,622,876
3,779,621 shares
 — 30 Sep 2025
Cowen Financial Products LLC
13D/G
13D/G
4.9%
$94,926,816
1,909,228 shares
 $0 31 Dec 2024
MORGAN STANLEY
13F 13D/G
Company
13F 13D/G
4.7%
from 13D/G
$113,654,091
1,912,402 shares
 — 30 Sep 2025
TANG CAPITAL MANAGEMENT LLC
13F 13D/G
Company
13F 13D/G
2.8%
from 13D/G
$145,888,586
2,454,797 shares
 — 30 Sep 2025
Deep Track Capital, LP
13F
Company
13F
7.1%
$178,290,000
3,000,000 shares
 — 30 Sep 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
246
Shares
44,051,147
Rows available
246
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
219
Q4 2025 holders
246
Holder diff
27
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 value Q4 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .